ST13P16: A Drug Target / Disease Biomarker (G100422605)

Target Name: ST13P16

NCBI ID: G100422605

ST13P16

Other Name(s): ST13, Hsp70 interacting protein pseudogene 16

ST13P16: A Drug Target / Disease Biomarker

ST13P16 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, which means it helps cells grow, divide, and prepare for cell death. ST13P16 is also involved in the development and maintenance of cancer.

Research has shown that ST13P16 is often expressed in various types of cancer, including breast, ovarian, and prostate cancer. It is also been found to be associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

One of the main reasons for the potential clinical applications of ST13P16 is its involvement in the regulation of the cell cycle. This is because ST13P16 is a key regulator of the G1/S checkpoint, which is a critical step in the cell cycle that helps cells prepare for cell death. If the G1/S checkpoint is not working properly, cells may continue to divide and proliferate, leading to the development of cancer.

In addition to its role in the cell cycle, ST13P16 has also been shown to play a role in the development and maintenance of neurodegenerative diseases. Studies have shown that ST13P16 is expressed in the brains of individuals with Alzheimer's and Parkinson's disease, and that it is involved in the development of neurodegeneration in these conditions.

Another potential clinical application of ST13P16 is its role in the regulation of inflammation. Inflammation is a natural response of the immune system, but when it becomes chronic or uncontrolled, it can lead to a range of diseases, including heart disease, cancer, and neurodegenerative diseases.

Research has shown that ST13P16 is involved in the regulation of inflammation by helping to control the movement of immune cells into the brain. This is important because when the immune system enters the brain, it can cause damage and contribute to the development of neurodegeneration. By inhibiting the movement of immune cells into the brain, ST13P16 may help to protect against this type of damage.

In conclusion, ST13P16 is a protein that is involved in a number of important biological processes in the cell cycle and in the development and maintenance of various types of cancer, as well as neurodegenerative diseases. Its potential clinical applications include as a drug target for cancer and neurodegenerative diseases. Further research is needed to fully understand the role of ST13P16 in these processes and to develop effective treatments.

Protein Name: ST13, Hsp70 Interacting Protein Pseudogene 16

The "ST13P16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST13P16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets